On a 40-pound weight loss, the difference is losing 46 pounds of muscle versus 1016 pounds
As Best Life reported, A previous study published in 2024 found that people using semaglutide are four times more likely to develop a rare but scary eye condition called nonarteritic anterior ischemic optic neuropathy, or NAION for short. This year, researcher and ophthalmologist Bradley Katz , PhD, discovered that both semaglutide and tirzepatide (the active ingredient in Zepbound and Mounjaro) can lead to NAION, as well as papillitis (inflammation of the optic nerve) and paracentral acute middle maculopathy (impacting your eyes blood vessels)
It is important to emphasize that evidence from these early reports is limited, and the efficacy and safety of FMT for ALS have not yet been established
However, as with any weight loss program, some users may experience mild and common side effects, such as slight digestive discomfort, occasional headaches, or a temporary increase in hunger as the body adjusts
FDA noted a theoretical concern that continuous telomerase activation could help abnormal cells avoid senescence
Thyroid hyperplasia and neoplasm adverse events associated with GLP-1 receptor agonists in FDA adverse event reporting system